Effects of lipopeptide carboxymethyl chitosan nanoparticles on Staphylococcus aureus biofilm

XH. Jiang, WM. Zhou, YZ. He, Y. Wang, B. Lv, XM. Wang

Article ID: 4380
Vol 31, Issue 3, 2017
DOI: https://doi.org/10.54517/jbrha4380
Received: 6 June 2022; Accepted: 6 June 2022; Available online: 6 June 2022; Issue release: 6 June 2022

Abstract

This study aims to evaluate the effect of lipopeptide carboxymethyl chitosan nanoparticles on Staphylococcus aureus biofilm as part of the development of a new anti-biofilm material. The study had three stages. Firstly, we assessed the Staphylococcus aureus capability to form biofilm and enumerated the number of attached bacteria and free bacteria; secondly, we determined the inhibitory effect of different concentrations of Bacillus natto antimicrobial lipopeptid- carboxymethyl chitosan (BNAP-CMCS) nanoparticles added at different times on biofilm formation capability and the numbers of free bacteria and attached bacteria. Lastly, we tested the scavenging effect of BNAP-CMCS nanoparticles on biofilm formation and number of attached bacteria. The results showed that the amount of attached bacteria quickly increased over time and reached the maximum after 24 h of culture. The BNAP-CMCS nanoparticles had the greatest effect on biofilm inhibition at the concentration of 1 MIC, after 8 h of culture, and the effect was dose-dependent. The BNAP-CMCS nanoparticles had decreased also the numbers of free and attached bacteria in a dose-dependent fashion, after 8 hours of culture. The scavenging effect of BNAP-CMCS nanoparticles on free and attached bacteria was maximum at 6 MIC. In conclusion, lipopeptide carboxymethyl chitosan nanoparticles had a good inhibition and scavenging effect on the formation of Staphylococcus aureus biofilm and the growth of surface-attached bacteria.


Keywords

carboxymethyl chitosan;nanoparticles;biofilm;Staphylococcus aureus


References

Supporting Agencies



Copyright (c) 2017 XH. Jiang, WM. Zhou, YZ. He, Y. Wang, B. Lv, XM. Wang




This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).